Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,645,747
-$1,716 QoQ
Shares Held
16,882
-2.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#375
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LEVEL FOUR ADVISORY SERVICES, LLC holds $97,082,688 across 12 Drug Manufacturers - General names. NVS ranks #9 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
135,146 | $34,008,139 | |
| 2 | JNJ |
Johnson & Johnson
|
65,905 | $16,737,892 | |
| 3 | NVO |
Novo Nordisk A S
|
197,413 | $9,463,979 | |
| 4 | MRK |
Merck & Co., Inc.
|
73,273 | $9,415,580 | |
| 5 | LLY |
ELI LILLY & Co
|
7,377 | $8,848,195 | |
| 6 | AMGN |
Amgen Inc
|
15,638 | $5,662,832 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
31,194 | $3,941,049 | |
| 8 | AZN |
Astrazeneca PLC
|
15,186 | $2,879,569 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,645,747 | 16,882 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,647,463 | 17,332 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,511,853 | 18,219 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,313,962 | 18,044 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,923,090 | 15,892 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,259,278 | 11,296 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $966,385 | 9,931 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,147,784 | 9,979 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,152,855 | 10,829 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,120,423 | 11,583 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,150,149 | 11,391 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,232,506 | 12,100 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,304,362 | 12,926 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $1,020,096 | 11,088 | Shares | Sole | 2023-06-05 | |
| 2022-12-31 | $806,591 | 8,891 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $881,031 | 11,591 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,017,656 | 12,039 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,190,328 | 13,565 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $740,171 | 8,462 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $898,353 | 10,985 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $283,117 | 3,103 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $259,089 | 3,031 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $328,710 | 3,481 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $312,099 | 3,589 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $381,239 | 4,365 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $335,406 | 4,068 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||